Tretinoin/benzoyl peroxide

Last updated

Tretinoin/benzoyl peroxide
Combination of
Tretinoin Retinoid
Benzoyl peroxide Oxidizing agent
Clinical data
Trade names Twyneo
Other namesS6G5T-3
License data
Routes of
administration 		Topical
ATC code
Legal status
Legal status
Identifiers
KEGG

Tretinoin/benzoyl peroxide, sold under the brand name Twyneo, is a fixed-dose combination medication used for the treatment of acne. [1] [2] It contains tretinoin, a vitamin A derivative, and benzoyl peroxide, an oxidizing agent. [3]

The combination was approved for medical use in the United States in July 2021. [2] [4] [5]

References

  1. 1 2 "Twyneo (tretinoin and benzoyl peroxide) cream, for topical use" (PDF). U.S. Food and Drug Administration. Archived from the original (PDF) on 28 July 2021.
  2. 1 2 "Sol-Gel Technologies Announces FDA Approval of Twyneo" (Press release). Sol-Gel Technologies Ltd. 27 July 2021. Retrieved 27 July 2021– via GlobeNewswire.
  3. ↑ Ochsendorf F (June 2015). "Clindamycin phosphate 1.2% / tretinoin 0.025%: a novel fixed-dose combination treatment for acne vulgaris". Journal of the European Academy of Dermatology and Venereology. 29 (Suppl 5): 8–13. doi: 10.1111/jdv.13185 . PMID   26059820. S2CID   29681121.
  4. ↑ "Twyneo: FDA-Approved Drugs". U.S. Food and Drug Administration (FDA). Archived from the original on 28 July 2021. Retrieved 27 July 2021.
  5. ↑ "NDA Approval: Twyneo" (PDF). U.S. Food and Drug Administration. 26 July 2021.


This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.